Key Events This Week
16 Mar: New 52-week low at Rs.1.17 (-15.83%)
17 Mar: Further 52-week low at Rs.1.05 (-10.26%)
18 Mar: Stock hits Rs.0.85 (-19.05%) amid heavy volume
19 Mar: Declines to Rs.0.77 (-9.41%) despite Sensex dip
20 Mar: Week closes at Rs.0.70 (-9.09%) on fresh 52-week low
16 March 2026: Stock Hits 52-Week Low at Rs.1.17 Amid Downtrend
Evexia Lifecare’s stock opened the week on a weak note, falling 15.83% to close at Rs.1.17, marking a fresh 52-week low. This decline reflected ongoing challenges as the stock traded below all key moving averages, signalling sustained bearish momentum. Despite the Sensex gaining 0.47% to 33,673.11, Evexia’s underperformance highlighted its divergence from broader market strength. The company’s long-term operating profit CAGR of -23.63% and low profitability metrics continued to weigh on investor sentiment.
17 March 2026: Further Decline to Rs.1.05 as Bearish Trend Persists
The downtrend intensified with the stock dropping another 10.26% to Rs.1.05, again hitting a 52-week low. Trading volumes remained elevated at 7.7 million shares, indicating sustained selling pressure. The Sensex advanced 0.79% to 33,940.18, underscoring the stock’s relative weakness. Technical indicators remained bearish, with the MACD and Bollinger Bands signalling downward momentum. The company’s valuation metrics showed a low price-to-book ratio of 0.40, suggesting price attractiveness, but this was overshadowed by poor earnings and a high P/E of 137.28.
18 March 2026: Sharp 19.05% Drop to Rs.0.85 on Heavy Volume
Evexia’s stock price plunged 19.05% to Rs.0.85, marking the steepest single-day fall of the week amid a surge in volume to nearly 20 million shares. This represented a 69.1% decline from the 52-week high of Rs.3.04. The Sensex rose 1.15% to 34,329.13, further emphasising the stock’s underperformance. Technical signals remained bearish across weekly and monthly charts, with Dow Theory assessments indicating mild bearishness. The company’s flat quarterly results for December 2025 failed to provide any positive catalyst.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
19 March 2026: New 52-Week Low at Rs.0.77 Despite Sensex Dip
The stock continued its slide, falling 9.41% to Rs.0.77, marking the fifth consecutive day of losses. The Sensex declined 3.13% to 33,255.16, but Evexia’s sharper drop of nearly 10% highlighted its ongoing struggles. The company’s Debt to EBITDA ratio of -1.00 times and low ROE of 0.88% underscored financial stress. Technical indicators remained bearish, with the stock trading below all major moving averages and momentum oscillators signalling downward pressure.
20 March 2026: Week Closes at Rs.0.70 on Fresh 52-Week Low
Evexia Lifecare’s stock closed the week at Rs.0.70, down 9.09% on the day and 49.64% for the week. This marked a new 52-week low and a 75.3% decline from the 52-week high of Rs.3.04. The Sensex rebounded 0.51% to 33,423.61, further emphasising the stock’s underperformance. Despite an attractive Enterprise Value to Capital Employed ratio of 0.8, the company’s weak profitability, flat quarterly results, and bearish technical outlook continue to weigh heavily on the stock.
Evexia Lifecare Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-16 | Rs.1.17 | -15.83% | 33,673.11 | +0.47% |
| 2026-03-17 | Rs.1.05 | -10.26% | 33,940.18 | +0.79% |
| 2026-03-18 | Rs.0.85 | -19.05% | 34,329.13 | +1.15% |
| 2026-03-19 | Rs.0.77 | -9.41% | 33,255.16 | -3.13% |
| 2026-03-20 | Rs.0.70 | -9.09% | 33,423.61 | +0.51% |
Key Takeaways
Persistent Downtrend: The stock recorded six consecutive sessions of decline, hitting new 52-week lows each day and losing nearly half its value in one week.
Financial Struggles: Negative operating profit CAGR of -23.63% over five years, flat quarterly results, and a 60.3% profit decline over the past year highlight ongoing fundamental weaknesses.
Valuation Contrasts: Despite an attractive price-to-book ratio of 0.40 and EV to capital employed of 0.8, the extremely high P/E of 137.28 and poor returns on equity and capital employed reflect limited earnings power.
Technical Bearishness: The stock consistently traded below all major moving averages with bearish MACD, Bollinger Bands, and Dow Theory signals, indicating sustained selling pressure.
Market Underperformance: Evexia Lifecare’s stock fell 49.64% versus a marginal 0.28% decline in the Sensex, underscoring its relative weakness amid a cautious market environment.
Micro-Cap Risks: The company’s micro-cap status and predominantly non-institutional shareholding contribute to volatility and liquidity challenges.
Conclusion
Evexia Lifecare Ltd’s stock experienced a severe decline during the week ending 20 March 2026, driven by weak financial fundamentals, disappointing quarterly results, and persistent bearish technical indicators. The stock’s underperformance relative to the Sensex and its sector peers highlights the challenges faced by this micro-cap edible oil company. While valuation metrics suggest some price attractiveness, the lack of earnings growth and poor profitability metrics continue to weigh heavily on investor sentiment. The downgrade to a Strong Sell rating by MarketsMOJO further reflects the cautious outlook. Overall, the stock remains under significant pressure with no immediate signs of reversal, underscoring the need for careful analysis before considering exposure.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
